VYNE Therapeutics
VYNE
VYNE
59 hedge funds and large institutions have $139M invested in VYNE Therapeutics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
5% more funds holding
Funds holding: 56 → 59 (+3)
0.06% more ownership
Funds ownership: 0.99% → 1.06% (+0.06%)
Holders
59
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$7.31M | |
| 2 | +$4.98M | |
| 3 | +$4.41M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.97M |
| 5 |
DM
Deerfield Management
New York
|
+$1.56M |
Top Sellers
| 1 | -$5.23M | |
| 2 | -$1.26M | |
| 3 | -$1.16M | |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$827K |
| 5 |
JPMorgan Chase & Co
New York
|
-$665K |